Research and insights
Coverage audits, landscape analyses, and method notes from the TrialForge team. How the data is built, and what it reveals.
2 insights
Research
We added China's drug trial registry. Here's what ClinicalTrials.gov alone misses
Three of every four CDE trials is not on ClinicalTrials.gov, a 63 percent bigger picture of China plus thousands of novel CDE-only drug assets.
Read the note →Coverage audit
Our coverage of cardiorenalmetabolic assets
The audit, in full: 100 percent of clinical-stage cardiorenalmetabolic assets with a ClinicalTrials.gov trial, held in TrialForge.
Read the note →